To study the profile of Candida isolates and antifungal susceptibility pattern of neonatal sepsis in a tertiary care hospital of North India

References

• Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2):285–291.
   PubMed Web of Science ®Google Scholar
• Benjamin DK, Stoll BJ, Gantz MG, et al. Neonatal candidiasis: epidemiology, risk factors, and clinical judgment. Pediatrics. 2010;126(4):e865–e873.
   PubMed Web of Science ®Google Scholar
• Benjamin DK, DeLong E, Cotten CM, et al. Mortality following blood culture in premature infants: increased with Gram-negative bacteremia and candidemia, but not Gram-positive bacteremia. J Perinatol. 2004;24(3):175–180.
   PubMedGoogle Scholar
• Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J. 1998;17(6):504–508.
   PubMed Web of Science ®Google Scholar
• Aliaga S, Clark RH, Laughon M, et al. Changes in the incidence of candidiasis in neonatal intensive care units. Pediatrics. 2014;133(2):236–242.
   PubMed Web of Science ®Google Scholar
• Chitnis AS, Magill SS, Edwards JR, et al. Trends in Candida central line-associated bloodstream infections among NICUs, 1999–2009. Pediatrics. 2012;130(1):e46–e52.
   PubMed Web of Science ®Google Scholar
• Benjamin DK, Stoll BJ, Fanaroff AA, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006;117(1):84–92.
   PubMed Web of Science ®Google Scholar
• Liu M, Huang S, Guo L, et al. Clinical features and risk factors for blood stream infections of Candida in neonates. Exp Ther Med. 2015;10(3):1139–1144.
   PubMed Web of Science ®Google Scholar
• Kelly MS, Benjamin DK, Smith PB. The epidemiology and diagnosis of invasive candidiasis among premature infants. Clin Perinatol. 2015;42(1):105–117.
   PubMed Web of Science ®Google Scholar
• Kaur H, Chakrabarti A. Strategies to reduce mortality in adult and neonatal candidemia in developing countries. J Fungi (Basel). 2017;3(3):41.
   Google Scholar
• Friedman S, Richardson SE, Jacobs SE, et al. Systemic Candida infection in extremely low birth weight infants: short term morbidity and long term neurodevelopmental outcome. Pediatr Infect Dis J. 2000;19(6):499–504.
   PubMed Web of Science ®Google Scholar
• Adams-Chapman I, Bann CM, Das A, et al. Neurodevelopmental outcome of extremely low birth weight infants with Candida infection. J Pediatr. 2013;163(4):961–967.e3.
   PubMed Web of Science ®Google Scholar
• Almirante B, Rodríguez D, Park BJ, et al. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2005;43(4):1829–1835.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol. 2002;40(10):3551–3557.
   PubMed Web of Science ®Google Scholar
• Diekema DJ, Messer SA, Brueggemann AB, et al. Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study. J Clin Microbiol. 2002;40(4):1298–1302.
   PubMed Web of Science ®Google Scholar
• Iwata K. Drug resistance in human pathogenic fungi. Eur J Epidemiol. 1992;8(3):407–421.
   PubMed Web of Science ®Google Scholar
• Jensen RH. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment. Dan Med J. 2016;63(10).
   Web of Science ®Google Scholar
• Arendrup MC. Candida and Candidaemia. Susceptibility and epidemiology. Dan Med J. 2013;60(11):B4698.
   PubMed Web of Science ®Google Scholar
• Lamba M, Sharma R, Sharma D, et al. Bacteriological spectrum and antimicrobial susceptibility pattern of neonatal septicaemia in a tertiary care hospital of North India. J Matern Fetal Neonatal Med. 2016;29(24):3993–3998.
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS document m27-A2. Wayne (PA): National Committee for Clinical Laboratory Standards; 2002.
   Google Scholar
• Takkar VP, Bhakoo ON, Narang A. Scoring system for the prediction of early neonatal infections. Indian Pediatr. 1974;11(9):597–600.
   PubMed Web of Science ®Google Scholar
• Goel N, Ranjan PK, Aggarwal R, et al. Emergence of nonalbicans Candida in neonatal septicemia and antifungal susceptibility: experience from a tertiary care center. J Lab Physicians. 2009;1(2):53–55.
   PubMedGoogle Scholar
• Beck-Sagué C, Jarvis WR. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990. National Nosocomial Infections Surveillance System. J Infect Dis. 1993;167(5):1247–1251.
   PubMed Web of Science ®Google Scholar
• Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis. 1995;20(6):1526–1530.
   PubMed Web of Science ®Google Scholar
• Juyal D, Sharma M, Pal S, et al. Emergence of non-albicans Candida species in neonatal candidemia. North Am J Med Sci. 2013;5(9):541–545.
   PubMedGoogle Scholar
• Nazir A, Masoodi T. Spectrum of candidal species isolated from neonates admitted in an Intensive Care Unit of teaching hospital of Kashmir, North India. J Lab Physicians. 2018;10(3):255–259.
   PubMed Web of Science ®Google Scholar
• Capoor MR, Nair D, Deb M, et al. Emergence of non-albicans Candida species and antifungal resistance in a tertiary care hospital. Jpn J Infect Dis. 2005;58(6):344–348.
   PubMed Web of Science ®Google Scholar
• Xess I, Jain N, Hasan F, et al. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection. 2007;35(4):256–259.
   PubMed Web of Science ®Google Scholar
• Benjamin DK, DeLong ER, Steinbach WJ, et al. Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics. 2003;112(3):543–547.
   PubMed Web of Science ®Google Scholar
• Yu Y, Du L, Yuan T, et al. Risk factors and clinical analysis for invasive fungal infection in neonatal intensive care unit patients. Am J Perinatol. 2012;30(07):589–594.
   PubMed Web of Science ®Google Scholar
• Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J. 2000;19(4):319–324.
   PubMed Web of Science ®Google Scholar
• Sobel JD, Zervos M, Reed BD, et al. Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications. Antimicrob Agents Chemother. 2003;47(1):34–38.
   PubMed Web of Science ®Google Scholar
• Odds FC, Hanson MF, Davidson AD, et al. One year prospective survey of Candida bloodstream infections in Scotland. J Med Microbiol. 2007;56(8):1066–1075.
   PubMed Web of Science ®Google Scholar
• Narain S. Neonatal systemic candidiasis in a tertiary care centre. Indian J Med Microbiol. 2003;21(1):56–58.
   PubMedGoogle Scholar